Your browser doesn't support javascript.
loading
Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis.
Dolladille, Charles; Font, Jonaz; Bejan-Angoulvant, Theodora; Zaman, Khalil; Sassier, Marion; Ezine, Emilien; Stefan, Andreea; Plane, Anne-Flore; Legallois, Damien; Milliez, Paul; Parienti, Jean-Jacques; Alexandre, Joachim.
Afiliação
  • Dolladille C; Department of Pharmacology, CHU de Caen, 14000 Caen, France; Department of Cardiology, CHU de Caen, 14000 Caen, France. Electronic address: dolladille-c@chu-caen.fr.
  • Font J; Department of Pharmacology, CHU de Caen, 14000 Caen, France.
  • Bejan-Angoulvant T; Medical Pharmacology Department, CHRU Tours, 37044 Tours, France.
  • Zaman K; Lausanne University Hospital (CHUV) and Swiss Group for Clinical Cancer Research (SAKK), 1011 Lausanne, Switzerland.
  • Sassier M; Department of Pharmacology, CHU de Caen, 14000 Caen, France.
  • Ezine E; Department of Dermatology, CHU de Caen, 14000 Caen, France.
  • Stefan A; Department of Dermatology, CHU de Caen, 14000 Caen, France.
  • Plane AF; Department of Cardiology, CHU de Caen, 14000 Caen, France.
  • Legallois D; Department of Cardiology, CHU de Caen, 14000 Caen, France; Medical School, Université Caen Normandie, UNICAEN, CHU de Caen, EA 4650 (Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique), 14000 Caen, France.
  • Milliez P; Medical School, Université Caen Normandie, UNICAEN, CHU de Caen, EA 4650 (Signalisation, électrophysiologie et imagerie des lésions d'ischémie-reperfusion myocardique), 14000 Caen, France.
  • Parienti JJ; Department of Biostatistics and Clinical Research, CHU de Caen, 14000 Caen, France.
  • Alexandre J; Department of Pharmacology, CHU de Caen, 14000 Caen, France; Department of Cardiology, CHU de Caen, 14000 Caen, France; Department of Dermatology, CHU de Caen, 14000 Caen, France.
Arch Cardiovasc Dis ; 113(6-7): 420-432, 2020.
Article em En | MEDLINE | ID: mdl-32418884
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Fibrossarcoma / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Cardiovasc Dis Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Fibrossarcoma / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Cardiovasc Dis Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda